Who gets Alzheimer?

['Hör dir diese Seite an']

Wer kriegt Alzheimer?

De ziekte vaan Alzheimer is 'n progressieve neurodegeneratieve stoornis die veural ouwere lui treft.

't Risico op 't oontwikkele vaan Alzheimer kump mèt d'n tied touw en is 't algemeinste bij lui euver de 65.

De vreug beginnende Alzheimer kin evels veurkoume bij lui in de 30, 40 en 50 jaor, al is dit minder algemein.

Genetica sjpeelt ouch 'n rol in de oontwikkeling vaan de ziekte vaan Alzheimer.

Minse mèt 'n familiegesjiedenis vaan de krenkde höbbe 'n hoeger risico um 't zelf te oontwikkele.

Daoneve kinne bepaolde genetische mutaties, wie 't APOE-e4-gen, de kans op 't oontwikkele vaan Alzheimer vergroete.

Aander risicofactoren veur Alzheimer zien 'n historie vaan hoofletsel, hart- en vaatziekte en leefstijlfactoren wie rouke, euvergewich en gebrek aon oefening.

't Is belangriek te merke dat, hoewel bepaolde factore 't risico op 't oontwikkele vaan Alzheimer kinne vergroete, 't gein normaal deil vaan 't veroudering is, en neet ederein dee oud weurt zal de krenkde oontwikkele.

['Verwiezinge']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Kovacs GG: Can Creutzfeldt-Jakob disease unravel the mysteries of Alzheimer? Prion. 2016, 10 (5): 369-376.

Cankurtaran M, Yavuz BB, Cankurtaran ES, Halil M, Ulger Z, Ariogul S: Risk factors and type of dementia: vascular or Alzheimer? Arch Gerontol Geriatr. , 47 (1): 25-34.

Mahami-Oskouei M, Hamidi F, Talebi M, Farhoudi M, Taheraghdam AA, Kazemi T, Sadeghi-Bazargani H, Fallah E: Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer? Parasitol Res. 2016, 115 (8): 3169-74.

Vellas B, Andrieu S, Cantet C, Dartigues JF, Gauthier S: Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer? J Nutr Health Aging. , 11 (4): 338-41.

Bakhtiari S, Moghadam NB, Ehsani M, Mortazavi H, Sabour S, Bakhshi M: Can Salivary Acetylcholinesterase be a Diagnostic Biomarker for Alzheimer? J Clin Diagn Res. 2017, 11 (1): ZC58-ZC60.

['Disclaimer: medisch']

['Dees website is allein veur educatief en informatieve doele en is gein medisch advies of professionele deenste.']

["De verstrekte informatie moot neet weure gebruuk veur 't diagnosticere of behandele vaan 'n gezondheidsprobleem of -krenkde, en lui die medisch advies wèlle höbbe mote 't vraoge aon 'ne gecertificeerde dokter."]

["Bloadn woarin dat de antwoorden op de vraogen in 't neuraal netwark onnauwkeurig bint."]

["Vraog altied advies aon d'n dokter of aon 'n aander gekwalificeerde gezondheidsdeensverlener euver 'n medische toestand. Vergaet noets professioneel medisch advies of vertraog 't in te vraoge umtot get wat geer op dees website höb geleze. Es geer dink tot geer 'n medisch noodgeval höb, bel 911 of geit nao de naoste spoedeisende hulp. Gein arts-patiënt relatie weurt gecreëerd door dees website of 't gebruuk daovaan. Noch BioMedLib noch zien werknemers, noch eedere medewerker aon dees website, maak 'n verklaoring, expliciet of impliciet, mèt betrekking tot de informatie hei of op 't gebruuk daovaan."]

['Disclaimer: copyright']

["De Digital Millennium Copyright Act vaan 1998, 17 U.S.C. § 512 (de DMCA) zörg veur recourse veur copyright-eigenaere die geluive dat materiaal wat op 't internet versjijnt hun rechte oonder de Amerikaanse copyrightwetgeving schendt. "]

["Es geer good geluif dat content of materiaal wat in verband mèt eus website of deenste besjikbaar is, euvertrejt, kinne geer (of eur agent) us 'n berich sture boebij geer vraogt tot de content of 't materiaal weurt verwijderd of tot d'n toegang weurt geblokkeerd."]

['Aankondiginge mote weure gesjtuurd per e-mail (zuug de sectie "Contact" veur e-mailadres).']

["De DMCA vereis dat d'n aovend vaan vermeinde auteursrechsoortreding de volgende informatie bevat: (1) 'n Besjrieving vaan 't auteursrechsbesjermp werk wat 't oonderwerp is vaan de vermeinde euvertreding; (2) 'n Besjrieving vaan de vermeinde euvertrèkkende content en informatie genóg um us de content te laote opspoore; (3) contactinformatie veur diech, inclusief adres, telefoonnummer en e-mailadres; (4) 'n verklaoring vaan diech tot diech good geluif höbs tot de content op de klaagde meneer neet is geautoriseerd door de auteursrechseigenaer, of d'n agent, of door de werking vaan e wèt; "]

["(5) 'n oetlègk vaan diech, oonder straof vaan meineed, dat de informatie in de melding juus is en dat diech de autoriteit höbs um de auteursrechte die weure gesjend te handhaven;"]

["en (6) 'n fysieke of elektronische handtekening vaan de eigenaer vaan 't auteursrech of 'n persoen die gemachtigd is um namens de eigenaer vaan 't auteursrech te handelen. "]

["Es geer neet alle bovestaonde informatie geit geve, kin 't tot gevolg höbbe tot de behandeling vaan eur klach get later weurt."]

['Contact']

['Bitte schick uns eine E-Mail mit irgendwelchen Fragen/Vorschlägen.']

Who gets alzheimer?

Alzheimer's disease is a progressive neurodegenerative disorder that primarily affects older adults.

The risk of developing Alzheimer's disease increases with age, and it is most common in people over the age of 65.

However, early-onset Alzheimer's can occur in people in their 30s, 40s, and 50s, although this is less common.

Genetics also play a role in the development of Alzheimer's disease.

People with a family history of the disease are at a higher risk of developing it themselves.

Additionally, certain genetic mutations, such as the APOE-e4 gene, can increase the likelihood of developing Alzheimer's.

Other risk factors for Alzheimer's disease include a history of head injuries, cardiovascular disease, and lifestyle factors such as smoking, obesity, and lack of exercise.

It is important to note that while certain factors can increase the risk of developing Alzheimer's disease, it is not a normal part of aging, and not everyone who ages will develop the disease.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.